mitomycin has been researched along with Day Blindness in 29 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Excerpt | Relevance | Reference |
---|---|---|
"To report the first case of bilateral ocular decompression retinopathy after uneventful non-perforating deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome." | 7.96 | Bilateral decompression retinopathy after deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome. ( Díez-Álvarez, L; Garcia, CF; Muñoz-Negrete, FJ; Rebolleda, G, 2020) |
"The use of topical mitomycin (mitomycin-C) as a medical adjunct to pterygium and glaucoma surgery is increasing." | 7.68 | Serious complications of topical mitomycin-C after pterygium surgery. ( Foster, CS; Martin, NF; Pfister, RR; Rubinfeld, RS; Speaker, MG; Stein, RM; Stoleru, S; Talley, AR, 1992) |
"To compare the intraocular pressure and hypotony outcomes of primary phakic trabeculectomies with no mitomycin C (MMC), shorter MMC, and longer MMC exposure." | 5.08 | Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C. ( Ginde, SA; Kim, C; Kim, YY; Kupin, TH; Lee, D; Ren, J; Sexton, RM; Shin, DH, 1998) |
"To report the first case of bilateral ocular decompression retinopathy after uneventful non-perforating deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome." | 3.96 | Bilateral decompression retinopathy after deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome. ( Díez-Álvarez, L; Garcia, CF; Muñoz-Negrete, FJ; Rebolleda, G, 2020) |
"To evaluate the efficacy, refractive predictability and stability, and complications of photorefractive keratectomy (PRK) with adjunctive mitomycin C (MMC) in patients with postkeratoplasty anisometropia." | 3.79 | Photorefractive keratectomy modification of postkeratoplasty anisometropic refractive errors. ( Goins, KM; Kitzmann, AS; Sutphin, JE; Wagoner, MD; Wandling, GR; Ward, MS, 2013) |
"To evaluate whether patients who have undergone trabeculectomy with mitomycin C have a different intraocular pressure (IOP) response profile after the water drinking test (WDT) from that of patients who are medically managed with a similar baseline IOP and level of visual field (VF) damage." | 3.74 | Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test. ( Danesh-Meyer, HV; Gamble, GD; Papchenko, T; Tan, YW, 2008) |
"The use of topical mitomycin (mitomycin-C) as a medical adjunct to pterygium and glaucoma surgery is increasing." | 3.68 | Serious complications of topical mitomycin-C after pterygium surgery. ( Foster, CS; Martin, NF; Pfister, RR; Rubinfeld, RS; Speaker, MG; Stein, RM; Stoleru, S; Talley, AR, 1992) |
"To report the 5-year incidence of visual impairment after mitomycin C-augmented trabeculectomy (MMC trabeculectomy) and the risk factors for visual impairment." | 1.43 | Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C. ( Araie, M; Chiba, T; Kashiwagi, K; Kogure, S; Kuwayama, Y; Mabuchi, F; Yamamoto, T, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (17.24) | 18.2507 |
2000's | 9 (31.03) | 29.6817 |
2010's | 13 (44.83) | 24.3611 |
2020's | 2 (6.90) | 2.80 |
Authors | Studies |
---|---|
Gedde, SJ | 1 |
Vinod, K | 1 |
Prum, BE | 1 |
Wilde, C | 1 |
Messina, M | 1 |
Dua, HS | 1 |
Nikita, E | 1 |
Murdoch, I | 1 |
Muñoz-Negrete, FJ | 1 |
Díez-Álvarez, L | 1 |
Garcia, CF | 1 |
Rebolleda, G | 1 |
Santhiago, MR | 1 |
Foulsham, WS | 1 |
Fu, L | 1 |
Tatham, AJ | 1 |
Majmudar, PA | 2 |
Schallhorn, SC | 1 |
Cason, JB | 1 |
Donaldson, KE | 1 |
Kymionis, GD | 1 |
Shtein, RM | 1 |
Verity, SM | 1 |
Farjo, AA | 1 |
Miraftab, M | 1 |
Hashemi, H | 1 |
Asgari, S | 1 |
Kashiwagi, K | 1 |
Kogure, S | 1 |
Mabuchi, F | 1 |
Chiba, T | 1 |
Yamamoto, T | 3 |
Kuwayama, Y | 1 |
Araie, M | 1 |
Prata, TS | 2 |
De Moraes, CG | 2 |
Palmiero, PM | 1 |
Tello, C | 2 |
Liebmann, J | 1 |
Ritch, R | 2 |
Leccisotti, A | 1 |
Folgar, FA | 1 |
Teng, CC | 1 |
Liebmann, JM | 1 |
Aoyama, A | 1 |
Ishida, K | 1 |
Sawada, A | 1 |
Liu, A | 1 |
Manche, EE | 1 |
Francis, BA | 1 |
Hong, B | 1 |
Winarko, J | 1 |
Kawji, S | 1 |
Dustin, L | 1 |
Chopra, V | 1 |
Ward, MS | 1 |
Wandling, GR | 1 |
Goins, KM | 1 |
Sutphin, JE | 1 |
Kitzmann, AS | 1 |
Wagoner, MD | 1 |
Lane, HA | 1 |
Swale, JA | 1 |
Grigorian, AP | 1 |
Spaeth, G | 1 |
Arikan, G | 1 |
Saatci, AO | 1 |
Soylev, MF | 1 |
Kocak, N | 1 |
Law, SK | 1 |
Nguyen, AM | 1 |
Coleman, AL | 1 |
Caprioli, J | 1 |
Char, DH | 1 |
Danesh-Meyer, HV | 1 |
Papchenko, T | 1 |
Tan, YW | 1 |
Gamble, GD | 1 |
Lu, DW | 1 |
Azuara-Blanco, A | 1 |
Katz, LJ | 1 |
Morales, J | 1 |
Good, D | 1 |
Kim, YY | 1 |
Sexton, RM | 1 |
Shin, DH | 1 |
Kim, C | 1 |
Ginde, SA | 1 |
Ren, J | 1 |
Lee, D | 1 |
Kupin, TH | 1 |
Cordeiro, MF | 1 |
Plant, GT | 1 |
Child, A | 1 |
Jones, B | 1 |
Khaw, PT | 1 |
Hagiwara, Y | 1 |
Kitazawa, Y | 1 |
Rubinfeld, RS | 1 |
Pfister, RR | 1 |
Stein, RM | 1 |
Foster, CS | 1 |
Martin, NF | 1 |
Stoleru, S | 1 |
Talley, AR | 1 |
Speaker, MG | 1 |
2 reviews available for mitomycin and Day Blindness
Article | Year |
---|---|
Results from the Primary Tube Versus Trabeculectomy Study and translation to clinical practice.
Topics: Adolescent; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; M | 2023 |
Mitomycin-C in corneal surface excimer laser ablation techniques: a report by the American Academy of Ophthalmology.
Topics: Academies and Institutes; Alkylating Agents; Combined Modality Therapy; Cornea; Corneal Surgery, Las | 2015 |
3 trials available for mitomycin and Day Blindness
Article | Year |
---|---|
Matched optical quality comparison of 3-year results of PRK-MMC and phakic IOL implantation in the correction of high myopia.
Topics: Adult; Alkylating Agents; Contrast Sensitivity; Female; Humans; Lasers, Excimer; Lens Implantation, | 2015 |
Mitomycin-C in hyperopic photorefractive keratectomy.
Topics: Administration, Topical; Adult; Alkylating Agents; Astigmatism; Cell Count; Corneal Opacity; Corneal | 2009 |
Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens, Crystalline; Male; Middle Ag | 1998 |
24 other studies available for mitomycin and Day Blindness
Article | Year |
---|---|
Management of recurrent epithelial ingrowth following laser in situ keratomileusis with mechanical debridement, alcohol, mitomycin-C, and fibrin glue.
Topics: Corneal Diseases; Debridement; Epithelium, Corneal; Ethanol; Fibrin Tissue Adhesive; Humans; Keratom | 2017 |
Same-site surgical revision of failed trabeculectomy blebs with mitomycin C augmentation: long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2018 |
Bilateral decompression retinopathy after deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome.
Topics: Alkylating Agents; Child; Combined Modality Therapy; Female; Humans; Intraocular Pressure; Mitomycin | 2020 |
Refractive surgical problem: December consultation #1.
Topics: Adult; Alkylating Agents; Corneal Endothelial Cell Loss; Endothelium, Corneal; Epikeratophakia; Fema | 2014 |
Visual improvement following glaucoma surgery: a case report.
Topics: Alkylating Agents; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Male; Middle Aged | 2014 |
Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Exfoliatio | 2016 |
Slit-lamp-adapted optical coherence tomography for assessment of an overhanging filtering bleb.
Topics: Aged; Alkylating Agents; Blister; Combined Modality Therapy; Conjunctival Diseases; Diagnostic Techn | 2010 |
Glaucoma surgery decreases the rates of localized and global visual field progression.
Topics: Algorithms; Disease Progression; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular P | 2010 |
Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma.
Topics: Adult; Aged; Alkylating Agents; Disease Progression; Female; Follow-Up Studies; Humans; Intraocular | 2010 |
Visually significant haze after retreatment with photorefractive keratectomy with mitomycin-C following laser in situ keratomileusis.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Opacity; Female; Humans; Keratomileusis | 2010 |
Vision loss and recovery after trabeculectomy: risk and associated risk factors.
Topics: Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Postoperative Complications; | 2011 |
Photorefractive keratectomy modification of postkeratoplasty anisometropic refractive errors.
Topics: Adult; Aged; Alkylating Agents; Anisometropia; Eyeglasses; Female; Humans; Intraoperative Complicati | 2013 |
Prophylactic use of mitomycin-C in the management of a buttonholed LASIK flap.
Topics: Adult; Antibiotics, Antineoplastic; Cicatrix; Female; Humans; Keratomileusis, Laser In Situ; Lasers, | 2003 |
An explanation of transient visual loss associated with leaking filtering bleb.
Topics: Aqueous Humor; Cornea; Female; Fluorophotometry; Glaucoma; Humans; Middle Aged; Mitomycin; Postopera | 2004 |
Bilateral combined cilioretinal artery and central retinal vein occlusion.
Topics: Arterial Occlusive Diseases; Ciliary Arteries; Diabetes Mellitus, Type 2; Fundus Oculi; Glaucoma, Ne | 2006 |
Consultation section: cataract surgical problem.
Topics: Anisometropia; Anterior Chamber; Cataract; Choroid Diseases; Combined Modality Therapy; Female; Glau | 2007 |
Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Disease Progression; Female; Follow-Up Studies; G | 2007 |
Complications of management in primary acquired melanosis with atypia.
Topics: Combined Modality Therapy; Conjunctival Diseases; Cryosurgery; Female; Humans; Melanosis; Middle Age | 2007 |
Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Diagnostic Techniques, | 2008 |
Severe visual loss after autologous blood injection for mitomycin-C-associated hypotonous maculopathy.
Topics: Adult; Blood; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macula Lutea; Male; Mi | 1997 |
Permanent glaucomatous visual loss after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Cornea; Dexamethasone; Filtering Surgery; | 1998 |
Visual loss after primary trabeculotomy with mitomycin C in Ehlers-Danlos syndrome.
Topics: Child; Ehlers-Danlos Syndrome; Female; Humans; Mitomycin; Nucleic Acid Synthesis Inhibitors; Trabecu | 1999 |
The effect of mitomycin C trabeculectomy on the progression of visual field defect in normal-tension glaucoma.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Disease Progression; Female; Glaucoma, Open-Angle; Humans; Intr | 2000 |
Serious complications of topical mitomycin-C after pterygium surgery.
Topics: Adult; Aged; Calcinosis; Cataract; Contraindications; Corneal Diseases; Eye Diseases; Female; Humans | 1992 |